Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies

References

• Caforio ALP, Goldman JH, Haven AJ, Baig KM, McKenna WJ. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Int J Cardiol 1996; 54: 157–163
   PubMed Web of Science ®Google Scholar
• Brown CA, O'Connell JB. Myocarditis and idiopathic dilated cardiomyopathy. Am J Med 1995; 99: 309–314
   PubMed Web of Science ®Google Scholar
• Felker GM, Hu W, Hare JM, Hruban RH, Baughman KI, Kasper EK. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1278 patients. Medicine 1999; 78: 270–283
   PubMed Web of Science ®Google Scholar
• Aretz HT. Myocarditis: The Dallas criteria. Hum Pathol 1987; 18: 619–624
   PubMed Web of Science ®Google Scholar
• Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, Jr, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987; 1: 3–14
   PubMedGoogle Scholar
• Maisch B, Deeg P, Liebau G, Kochsiek K. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 1983; 52: 1072–1078
   PubMed Web of Science ®Google Scholar
• Maisch B, Trostel-Soeder R, Stechemesser E, Berg PA, Kochsiek K. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol 1982; 48: 533–545
   PubMed Web of Science ®Google Scholar
• Woodruff JF. Viral myocarditis—a review. Am J Pathol 1980; 101: 425–466
   PubMed Web of Science ®Google Scholar
• Towbin JA, Bowles KR, Bowles NE. Etiologies of cardiomyopathy and heart failure. Nat Med 1999; 5: 266–267
   PubMed Web of Science ®Google Scholar
• Huber SA, Job LP, Woodruff JF. Lysis of infected myofibers by coxsackievirus B3 immune lymphocytes. Am J Pathol 1980; 98: 681–694
   PubMed Web of Science ®Google Scholar
• Cooper LT, Jr. Giant cell myocarditis: Diagnosis and treatment. Herz 2000; 25: 291–298
   PubMed Web of Science ®Google Scholar
• Cooper LT, Jr., Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis—natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 1997; 336: 1860–1866
   PubMed Web of Science ®Google Scholar
• Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Gatewood SJ, et al. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am J Pathol 2004; 165: 1883–1894
   PubMed Web of Science ®Google Scholar
• Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Steele RA, et al. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J Immunol 2005; 174: 261–269
   PubMed Web of Science ®Google Scholar
• Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, et al. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 2006; 203: 2009–2019
   PubMed Web of Science ®Google Scholar
• Li Y, Heuser JS, Cunningham LC, Kosanke SD, Cunningham MW. Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol 2006; 177: 8234–8240
   PubMed Web of Science ®Google Scholar
• Morad M, Davies NW, Ulrich G, Schultheiss HP. Antibodies against ADP–ATP carrier enhance Ca2+ current in isolated cardiac myocytes. Am J Physiol 1988; 255: H960–H964
   Google Scholar
• Schultheiss HP, Schulze K, Schauer R, Witzenbichler B, Strauer BE. Antibody-mediated imbalance of myocardial energy metabolism. A causal factor of cardiac failure?. Circ Res 1995; 76: 64–72
   PubMed Web of Science ®Google Scholar
• Galvin JE, Hemric ME, Kosanke SD, Factor SM, Quinn A, Cunningham MW. Induction of myocarditis and valvulitis in Lewis rat by different epitopes of cardiac myosin and its implications in rheumatic carditis. Am J Pathol 2002; 160: 297–306
   PubMed Web of Science ®Google Scholar
• Kodama M, Matsumoto U, Fujiwara M, Masani F, Izumi T, Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 1990; 57: 250–262
   PubMedGoogle Scholar
• Li Y, Heuser JS, Kosanke SD, Hemric ME, Cunningham MW. Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat. J Immunol 2004; 172: 3225–3234
   PubMed Web of Science ®Google Scholar
• Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987; 139: 3630–3636
   PubMed Web of Science ®Google Scholar
• Kuan AP, Chamberlain W, Malkeil S, Lieu HD, Factor SM, Diamond B, et al. Genetic control of autoimmune myocarditis mediated by myosin-specific antibodies. Immunogenetics 1999; 49: 595–596
   Web of Science ®Google Scholar
• Kuan AP, Zuckier L, Liao L, Factor SM, Diamond B. Immunoglobulin isotype determines pathogenicity in antibody-mediated myocarditis in naive mice. Circ Res 2000; 86: 281–285
   PubMed Web of Science ®Google Scholar
• Liao L, Sindhwani R, Rojkind M, Factor S, Leinwand L, Diamond B. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med 1995; 181: 1123–1131
   PubMed Web of Science ®Google Scholar
• Neumann DA, Lane JR, Wulff SM, Allen GS, LaFond-Walker A, Herskowitz A, et al. In vivo deposition of myosin-specific autoantibodies in the hearts of mice with experimental autoimmune myocarditis. J Immunol 1992; 148: 3806–3813
   PubMed Web of Science ®Google Scholar
• Caforio AL, Mahon NJ, McKenna WJ. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity 2001; 34: 199–204
   PubMed Web of Science ®Google Scholar
• Lauer B, Schannwell M, Kuhl U, Strauer BE, Schultheiss HP. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 2001; 37: 1106–1110
   PubMedGoogle Scholar
• Maisch B, Deeg P, Liebau G, Kochsiek K. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 1983; 52: 1072–1078
   PubMed Web of Science ®Google Scholar
• Neumann DA, Burek CL, Baughman KL, Rose NR, Herskowitz A. Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol 1990; 16: 839–846
   PubMedGoogle Scholar
• Felix SB, Staudt A, Friedrich GB. Improvement of cardiac function after immunoadsorption in patients with dilated cardiomyopathy. Autoimmunity 2001; 34: 211–215
   PubMed Web of Science ®Google Scholar
• Rose NR. The significance of autoimmunity in myocarditis. Ernst Schering Res Found Workshop 2006; 55: 141–154
   Google Scholar
• Chow LH, Yuling Y, Linder J, McManus BM. Phenotypic analysis of infiltrating cells in human myocarditis. Arch Pathol Lab Med 1989; 113: 1357–1362
   PubMed Web of Science ®Google Scholar
• Cunningham MW, Antone SM, Gulizia JM, McManus BA, Gauntt CJ. Alpha-helical coiled-coil molecules: A role in autoimmunity against the heart. Clin Immunol Immunopathol 1993; 68: 129–134
   PubMedGoogle Scholar
• Cunningham MW, Antone SM, Gulizia JM, McManus BM, Fischetti VA, Gauntt CJ. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci USA 1992; 89: 1320–1324
   PubMed Web of Science ®Google Scholar
• Liao L, Sindhwani R, Rojkind M, Factor S, Leinwand L, Diamond B. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med 1995; 187: 1123–1131
   Google Scholar
• Antone SM, Adderson EE, Mertens NMJ, Cunningham MW. Molecular analysis of V gene sequences encoding cytotoxic anti-streptococcal/anti-myosin monoclonal antibody 36.2.2 that recognizes the heart cell surface protein laminin. J Immunol 1997; 159: 5422–5430
   PubMed Web of Science ®Google Scholar
• Tobacman LS, Adelstein RS. Enzymatic comparisons between light chain isozymes of human cardiac myosin subfragment-1. J Biol Chem 1984; 259: 11226–11230
   PubMed Web of Science ®Google Scholar
• Galvin JE, Hemric ME, Ward K, Cunningham MW. Cytotoxic monoclonal antibody from rheumatic carditis reacts with human endothelium: Implications in rheumatic heart disease. J Clin Invest 2000; 106: 217–224
   PubMed Web of Science ®Google Scholar
• Jaenicke T, Diederich KW, Haas W, Scheich J, Lichter P, Pfordt M, et al. Complete sequence of human b myosin. Genomics 1990; 8: 194–207
   PubMed Web of Science ®Google Scholar
• Cunningham MW, Meissner HC, Heuser J, Leung DYM. Anti-human cardiac myosin autoantibodies in Kawasaki syndrome. J Immunol 1999; 163: 1060–1065
   PubMed Web of Science ®Google Scholar
• Cunningham MW, Swerlick RA. Polyspecificity of antistreptococcal murine monoclonal antibodies and their implications in autoimmunity. J Exp Med 1986; 164: 998–1012
   PubMed Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 277: 680
   Web of Science ®Google Scholar
• Caforio AL, Goldman JH, Baig MK, Haven AJ, Dalla Libera L, Keeling PJ, et al. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart 1997; 77: 62–67
   PubMed Web of Science ®Google Scholar
• Caforio AL, Goldman JH, Haven AJ, Baig KM, Libera LD, McKenna WJ. Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. The myocarditis treatment trial investigators. Eur Heart J 1997; 18: 270–275
   PubMed Web of Science ®Google Scholar
• Caforio AL, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, et al. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992; 85: 1734–1742
   PubMed Web of Science ®Google Scholar
• Caforio AL, Mahon NG, McKenna WJ. Clinical implications of anti-cardiac immunity in dilated cardiomyopathy. Ernst Schering Res Found Workshop 2006; 169–193
   PubMedGoogle Scholar
• Caforio AL, Mahon NJ, McKenna WJ. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity 2001; 34: 199–204
   PubMed Web of Science ®Google Scholar
• Caforio AL, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: Pathogenetic and clinical significance. Eur J Heart Fail 2002; 4: 411–417
   PubMed Web of Science ®Google Scholar
• Kodama M, Hanawa H, Zhang S, Saeki M, Koyama S, Hosono H, et al. FK506 therapy of experimental autoimmune myocarditis after onset of the disease. Am Heart J 1993; 126: 1385–1392
   PubMed Web of Science ®Google Scholar
• Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T, Suzuki K, et al. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 1994; 75: 278–284
   PubMed Web of Science ®Google Scholar
• Kodama M, Matsumoto Y, Fujiwara M, Massani M, Izumi T, Shibota A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 1991; 57: 250–262
   Google Scholar
• Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987; 139: 3630–3636
   PubMed Web of Science ®Google Scholar
• Smith SC, Allen PM. Myosin-induced acute myocarditis is a T cell mediated disease. J Immunol 1991; 147: 2141–2147
   PubMed Web of Science ®Google Scholar
• Galvin JE, Hemric ME, Kosanke SD, Factor SM, Quinn A, Cunningham MW. Induction of myocarditis and valvulitis in Lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis. Am J Pathol 2001; 160: 297–306
   Web of Science ®Google Scholar
• Liao L, Sindhwani R, Leinwand L, Diamond B, Factor S. Cardiac alpha-myosin heavy chains differ in their induction of myocarditis: Identification of pathogenic epitopes. J Clin Invest 1993; 92: 2877
   PubMed Web of Science ®Google Scholar
• Cunningham MW, McCormack JM, Fenderson PG, Ho MK, Beachey EH, Dale JB. Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol 1989; 143: 2677–2683
   PubMed Web of Science ®Google Scholar
• Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13: 470–511
   PubMed Web of Science ®Google Scholar
• Cunningham MW, McCormack JM, Talaber LR, Harley JB, Ayoub EM, Muneer RS, et al. Human monoclonal antibodies reactive with antigens of the group A streptococcus and human heart. J Immunol 1988; 141: 2760–2766
   PubMed Web of Science ®Google Scholar
• Rose NR. The role of infection in the pathogenesis of autoimmune disease. Semin Immunol 1998; 10: 5–13
   PubMed Web of Science ®Google Scholar
• Kirvan CA, Swedo SE, Heuser S, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003; 9: 914–920
   PubMed Web of Science ®Google Scholar
• Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature 2002; 415: 206–212
   PubMedGoogle Scholar
• Freedman NJ, Lefkowitz RJ. Anti-beta-1-adrenergic receptor antibodies and heart failure: Causation, not just correlation. J Clin Invest 2004; 113: 1379–1382
   PubMed Web of Science ®Google Scholar
• Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, et al. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004; 113: 1419–1429
   PubMed Web of Science ®Google Scholar
• Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, et al. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004; 113: 1419–1429
   PubMed Web of Science ®Google Scholar
• Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526–1533
   PubMed Web of Science ®Google Scholar